
Hereditary Complement Deficiency Diseases, Glomerulonephritis, Membranoproliferative, Complement, Complement System Proteins, Eculizumab, Japan, Complement Factor H, Hemolytic-Uremic Syndrome, Mutation, Practice Guidelines as Topic, Hemolytic uremic syndrome, Humans, Complement Regulatory factors, Kidney Diseases, Atypical Hemolytic Uremic Syndrome, Signal Transduction
Hereditary Complement Deficiency Diseases, Glomerulonephritis, Membranoproliferative, Complement, Complement System Proteins, Eculizumab, Japan, Complement Factor H, Hemolytic-Uremic Syndrome, Mutation, Practice Guidelines as Topic, Hemolytic uremic syndrome, Humans, Complement Regulatory factors, Kidney Diseases, Atypical Hemolytic Uremic Syndrome, Signal Transduction
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
